Evidence map›Paper›PMID 31073890›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Evaluation of MALDI-TOF/TOF Mass Spectrometry Approach for Quantitative Determination of Aspartate Residue Isomerization in the Amyloid-β Peptide.

Stanislav I Pekov, Daniil G Ivanov, Anna E Bugrova, Maria I Indeykina, Natalia V Zakharova, Igor A Popov, Alexey S Kononikhin, Sergey A Kozin, Alexander A Makarov, Evgeny N Nikolaev

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stanislav I PekovMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia.ORCID http://orcid.org/0000-0002-9622-3457
Daniil G IvanovMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia.
Anna E BugrovaEmanuel Institute of Biochemical Physics RAS, Moscow, Russia.
Maria I IndeykinaMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia.
Natalia V ZakharovaMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia.
Igor A PopovMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia. popov.ia@phystech.edu.
Alexey S KononikhinMoscow Institute of Physics and Technology, Dolgoprudny, Moscow region, Russia. alex.kononikhin@gmail.com.
Sergey A KozinEngelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Alexander A MakarovEngelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Evgeny N NikolaevSkolkovo Institute of Science and Technology, Skolkovo, Russia.

Funding

Russian Science Foundation 16-14-00181Russian Science Foundation 19-74-30007
6 · The paper itself

Abstract

Immunoprecipitation (IP) combined with MALDI-TOF mass spectrometry is a powerful instrument for peptide and protein identification in biological samples. In this study, the analytical capabilities of MALDI-TOF/TOF mass spectrometry for relative quantitation of isoAsp7 in Aβ(1-42) and Aβ(1-16) were investigated. The possibility of quantitative determination of isoAsp7 in Aβ(1-42) with the detection limit as low as 2 pmol has been demonstrated. The same approach was applied for a shorter peptide Aβ(1-16) and resulted in enhanced accuracy (± 3.2%), and lower detection limit (50 fmol). Pilot experiments with artificial cerebrospinal fluid and mouse brain tissue were performed and showed that the proposed IP-MALDI-TOF/TOF approach could be applied for measuring isoAβ content in biological fluids and tissues. Additionally, it was shown that 6E10 anti-amyloid antibodies might affect the accuracy of the amyloid-β quantitation in the presence of the isomerized peptide.

Indexed as

Amyloid beta-PeptidesAnimalsAspartic AcidBrain ChemistryHumansIsomerismMiceMice, TransgenicPeptide FragmentsSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionizationamyloid beta-peptide (4-16)Amyloid beta-Peptidesamyloid beta-protein (1-42)Aspartic AcidPeptide FragmentsAmyloid-βImmunoprecipitationIsomerizationMALDI

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.